Table 2.
Correlations | Control group (n = 20) | Persons with prediabetes (n = 30) | Persons with type 2 diabetes on insulin therapy (n = 30) |
---|---|---|---|
YKL-40/age | r = 0.243, p = 0.302 | r = −0.073, p = 0.703 | r = 0.046, p = 0.809 |
Hepcidin/Glucose | r = 0.150, p = 0.528 | r = 0.342, p = 0.064 | r = −0.227, p = 0.228 |
Hepcidin/HbA1C | r = −0.154, p = 0.517 | r = 0.210, p = 0.266 | r = 0.112, p = 0.556 |
Hepcidin/Ferritin | r = −0.081, p = 0.734 | r = 0.082, p = 0.666 | r = 0.132, p = 0.486 |
Hepcidin/YKL-40 | r = 0.188, p = 0.427 | r = −0.034, p = 0.858 | r = −0.358, p = 0.052 |
Ferritin/YKL-40 | r = −0.173, p = 0.466 | r = −0.135, p = 0.476 | r = −0.009, p = 0.964 |
BMI/WHtR | r = 0.460, p = 0.041 | r = 0.828, p < 0.001 | r = 0.459, p = 0.011 |
HR/SBP | r = 0.800, p < 0.001 | r = 0.767, p < 0.001 | r = 0.630, p < 0.001 |
HR/DBP | r = 0.531, p = 0.016 | r = 0.873, p < 0.001 | r = 0.657, p < 0.001 |
Significant correlations are shown in bold (p < 0.05)